Wed, July 17, 2024
Tue, July 16, 2024
Mon, July 15, 2024

Douglas Tsao Reiterated (VRDN) at Strong Buy and Held Target at $27 on, Jul 16th, 2024


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. -buy-and-held-target-at-27-on-jul-16th-2024.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Douglas Tsao of HC Wainwright & Co., Reiterated "Viridian Therapeutics, Inc." (VRDN) at Strong Buy and Held Target at $27 on, Jul 16th, 2024.

Douglas has made no other calls on VRDN in the last 4 months.



There are 6 other peers that have a rating on VRDN. Out of the 6 peers that are also analyzing VRDN, 2 agree with Douglas's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Kalpit Patel of "B. Riley Securities" Downgraded from Strong Buy to Hold and Decreased Target to $20 on, Thursday, May 9th, 2024
  • Michael Higgins of "Ladenburg Thalmann" Downgraded from Strong Buy to Hold on, Thursday, May 9th, 2024


These are the ratings of the 4 analyists that currently disagree with Douglas


  • Andy Chen of "Wolfe Research" Initiated at Buy on, Tuesday, June 11th, 2024
  • Serge Belanger of "Needham" Reiterated at Strong Buy and Held Target at $30 on, Tuesday, June 11th, 2024
  • Richard Law of "Goldman Sachs" Initiated at Strong Buy and Held Target at $23 on, Thursday, June 6th, 2024
  • Leland Gershell of "Oppenheimer" Maintained at Buy with Decreased Target to $31 on, Thursday, May 9th, 2024

Publication Contributing Sources